- Home
- JMM vs ASRT Comparison
JMM vs ASRT Comparison
Compare JMM & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMM
- ASRT
- Stock Information
- Founded
- JMM 1988
- ASRT 1995
- Country
- JMM United States
- ASRT United States
- Employees
- JMM N/A
- ASRT N/A
- Industry
- JMM Trusts Except Educational Religious and Charitable
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- JMM Finance
- ASRT Health Care
- Exchange
- JMM Nasdaq
- ASRT Nasdaq
- Market Cap
- JMM 58.5M
- ASRT 57.9M
- IPO Year
- JMM N/A
- ASRT 1997
- Fundamental
- Price
- JMM $6.18
- ASRT $0.66
- Analyst Decision
- JMM
- ASRT Strong Buy
- Analyst Count
- JMM 0
- ASRT 3
- Target Price
- JMM N/A
- ASRT $3.08
- AVG Volume (30 Days)
- JMM 16.1K
- ASRT 284.6K
- Earning Date
- JMM 01-01-0001
- ASRT 05-12-2025
- Dividend Yield
- JMM 5.44%
- ASRT N/A
- EPS Growth
- JMM N/A
- ASRT N/A
- EPS
- JMM N/A
- ASRT N/A
- Revenue
- JMM N/A
- ASRT $119,001,000.00
- Revenue This Year
- JMM N/A
- ASRT N/A
- Revenue Next Year
- JMM N/A
- ASRT $11.71
- P/E Ratio
- JMM N/A
- ASRT N/A
- Revenue Growth
- JMM N/A
- ASRT N/A
- 52 Week Low
- JMM $5.29
- ASRT $0.51
- 52 Week High
- JMM $6.10
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- JMM 55.51
- ASRT 50.57
- Support Level
- JMM $6.05
- ASRT $0.67
- Resistance Level
- JMM $6.21
- ASRT $0.71
- Average True Range (ATR)
- JMM 0.12
- ASRT 0.04
- MACD
- JMM 0.00
- ASRT 0.00
- Stochastic Oscillator
- JMM 63.33
- ASRT 52.69
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.